JACOBS LEVY EQUITY MANAGEMENT, INC
Position in CTMX — CytomX Therapeutics, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in CTMX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$321,376
+$159,411 QoQ
Shares Held
68,378
+34.7% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in CTMX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $321,376 | 68,378 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $161,965 | 50,773 | Shares | Sole | 2025-11-17 | |
| 2025-03-31 | $436,428 | 686,208 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,593,631 | 1,547,215 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,798,409 | 1,524,076 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,839,414 | 1,507,717 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,155,258 | 529,935 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,226,702 | 791,421 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,357,215 | 1,052,105 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $2,788,823 | 1,621,409 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,855,992 | 1,891,386 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,059,027 | 661,892 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,586,761 | 1,094,318 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,640,501 | 896,449 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,870,543 | 1,075,110 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,364,484 | 1,238,911 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,095,816 | 1,394,070 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,949,778 | 1,413,867 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,617,886 | 597,398 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,957,641 | 604,220 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,087,901 | 614,722 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,528,104 | 423,542 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,863,902 | 243,012 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||